81 related articles for article (PubMed ID: 24403496)
1. The role of inhibitor of DNA-binding 1 (ID-1) protein and angiogenesis in serous ovarian cancer.
Kubelac MP; Fetica B; Vlad IC; Fulop A; Popa A; Achimas-Cadariu P
Anticancer Res; 2014 Jan; 34(1):413-6. PubMed ID: 24403496
[TBL] [Abstract][Full Text] [Related]
2. Id-1 overexpression in invasive ductal carcinoma cells is significantly associated with intratumoral microvessel density in ER-negative/node-positive breast cancer.
Jang KS; Han HX; Paik SS; Brown PH; Kong G
Cancer Lett; 2006 Dec; 244(2):203-10. PubMed ID: 16469432
[TBL] [Abstract][Full Text] [Related]
3. VEGF and Id-1 in pancreatic adenocarcinoma: prognostic significance and impact on angiogenesis.
Georgiadou D; Sergentanis TN; Sakellariou S; Filippakis GM; Zagouri F; Vlachodimitropoulos D; Psaltopoulou T; Lazaris AC; Patsouris E; Zografos GC
Eur J Surg Oncol; 2014 Oct; 40(10):1331-7. PubMed ID: 24480377
[TBL] [Abstract][Full Text] [Related]
4. Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors.
Schindl M; Schoppmann SF; Ströbel T; Heinzl H; Leisser C; Horvat R; Birner P
Clin Cancer Res; 2003 Feb; 9(2):779-85. PubMed ID: 12576450
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic value of microvessel density and angiogenesis-related molecules in epithelial ovarian cancer].
Tan XJ; Lang JH; Lou WZ; Shen K; Xu XY
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):274-8. PubMed ID: 18788631
[TBL] [Abstract][Full Text] [Related]
6. Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density.
Lösch A; Schindl M; Kohlberger P; Lahodny J; Breitenecker G; Horvat R; Birner P
Gynecol Oncol; 2004 Feb; 92(2):545-52. PubMed ID: 14766246
[TBL] [Abstract][Full Text] [Related]
7. Microvessel density and CpG island methylation of the THBS2 gene in malignant ovarian tumors.
Czekierdowski A; Czekierdowska S; Danilos J; Czuba B; Sodowski K; Sodowska H; Szymanski M; Kotarski J
J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():53-65. PubMed ID: 18955754
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of inhibitor of DNA-binding (ID)-1 protein related to angiogenesis in tumor advancement of ovarian cancers.
Maw MK; Fujimoto J; Tamaya T
BMC Cancer; 2009 Dec; 9():430. PubMed ID: 20003244
[TBL] [Abstract][Full Text] [Related]
9. Mast cell density, angiogenesis, blood clotting, and prognosis in women with advanced ovarian cancer.
Chan JK; Magistris A; Loizzi V; Lin F; Rutgers J; Osann K; DiSaia PJ; Samoszuk M
Gynecol Oncol; 2005 Oct; 99(1):20-5. PubMed ID: 16055178
[TBL] [Abstract][Full Text] [Related]
10. The effect of cyclooxygenase-2 expression on tumor vascularity in advanced stage ovarian serous carcinoma.
Ali-Fehmi R; Che M; Khalifeh I; Malone JM; Morris R; Lawrence WD; Munkarah AR
Cancer; 2003 Oct; 98(7):1423-9. PubMed ID: 14508829
[TBL] [Abstract][Full Text] [Related]
11. Microvessel density and p53 mutations in advanced-stage epithelial ovarian cancer.
Nadkarni NJ; Geest KD; Neff T; Young BD; Bender DP; Ahmed A; Smith BJ; Button A; Goodheart MJ
Cancer Lett; 2013 Apr; 331(1):99-104. PubMed ID: 23268330
[TBL] [Abstract][Full Text] [Related]
12. Ovarian serous carcinoma: relationship of p53 and bcl-2 with tumor angiogenesis and VEGF expression.
Crasta JA; Mishra S; Vallikad E
Int J Gynecol Pathol; 2011 Nov; 30(6):521-6. PubMed ID: 21979585
[TBL] [Abstract][Full Text] [Related]
13. Nuclear and cytoplasmic Id-1 expression patterns play different roles in angiogenesis and lymphangiogenesis in gastric carcinoma.
Si CF; Guo JQ; Yang YM; Zhang N; Pan CR; Zhang QH; Zhang TG; Zhou CJ
Ann Diagn Pathol; 2011 Feb; 15(1):46-51. PubMed ID: 21106425
[TBL] [Abstract][Full Text] [Related]
14. Expression of the angopoietin-1, angopoietin-2, Tie2, and vascular endothelial growth factor gene in epithelial ovarian cancer.
Hata K; Nakayama K; Fujiwaki R; Katabuchi H; Okamura H; Miyazaki K
Gynecol Oncol; 2004 Apr; 93(1):215-22. PubMed ID: 15047239
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Id-1 is associated with tumor angiogenesis and poor clinical outcome in oral squamous cell carcinoma.
Dong Z; Liu S; Zhou C; Sumida T; Hamakawa H; Chen Z; Liu P; Wei F
Oral Oncol; 2010 Mar; 46(3):154-7. PubMed ID: 20056476
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
[TBL] [Abstract][Full Text] [Related]
17. Expression of tumor suppressor gene ING4 in ovarian carcinoma is correlated with microvessel density.
Liu Y; Yu L; Wang Y; Zhang Y; Wang Y; Zhang G
J Cancer Res Clin Oncol; 2012 Apr; 138(4):647-55. PubMed ID: 22228137
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer.
Schindl M; Oberhuber G; Obermair A; Schoppmann SF; Karner B; Birner P
Cancer Res; 2001 Aug; 61(15):5703-6. PubMed ID: 11479201
[TBL] [Abstract][Full Text] [Related]
19. EphA2 overexpression is associated with angiogenesis in ovarian cancer.
Lin YG; Han LY; Kamat AA; Merritt WM; Landen CN; Deavers MT; Fletcher MS; Urbauer DL; Kinch MS; Sood AK
Cancer; 2007 Jan; 109(2):332-40. PubMed ID: 17154180
[TBL] [Abstract][Full Text] [Related]
20. Prognostic relevance of Id-1 expression in patients with resectable esophageal squamous cell carcinoma.
Luo KJ; Wen J; Xie X; Fu JH; Luo RZ; Wu QL; Hu Y
Ann Thorac Surg; 2012 May; 93(5):1682-8. PubMed ID: 22480390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
